Future Fields

Introducing Instar 1.0, our 6,000 square foot biofactory 🪰 Using fruit flies as sustainable bioreactors, Instar 1.0 will supply kilograms of recombinant proteins per year to meet increasing global demand. 🚀 Our co-founder and CEO gives a sneak peak of the impact and shares what this means for scientists developing the next generation of bioinnovations and medicine. 👇 Read the full story 👉 https://bit.ly/4fBPaKS

Jingle bells 🔔 growing cells 🧫 celebrating our last launch of the year! 🎉💜 Samples of sustainably made, fly-derived PDGF-BB are now available through our site. Request now to get yours in time before the holidays 🎄 👉 https://bit.ly/3BauJGs #PDGFBB #productlaunch

📢 PDGF-BB samples now available! 💜 This platelet-derived growth factor is expressed in our Drosophila-based EntoEngine™ and produced in our Green-certified lab. Our PDGF-BB is ready to support your research in bone grafting, tissue repair, angiogenesis, and beyond. From our lab to yours. 💌 Request a sample while quantities last! 👉 https://bit.ly/4iw89IU

Targeted Protein Degradation (TPD) is a rapidly evolving field with great potential for revolutionizing patient health. 🚀 Let's start with the basics. The fundamentals of protein degradation is the ubiquitin-proteasome system (UPS), illustrated below. 👇 Read more about TPD in our latest article 👉 https://bit.ly/3ZEhlDC

Happy flyday! 🪰 fun fly fact: we maintain stable lines of flies with the gene of interest with the help of balancer chromosomes. Watch the process below 🧬👇 Read more about leveraging genetic tools for recombinant protein expression 👉 https://bit.ly/3OKuO6N

Our Sustainability Committee delivered a presentation this week on the progress we made in 2024. 💚🌎♻️ Acting on the #climatecrisis is one our top company values, and we operationalize this with several projects on lab and office #sustainability. Some initiatives are small, incremental changes that we implement company-wide, such as proper waste sorting and turning off equipment when not in use. Other initiatives involve getting out into the community, such as our neighbourhood cleanups and clothing/food drives. We aren’t perfect, but we know that every climate action counts. Read more on our sustainability initiatives here 👉 https://bit.ly/3OHXqNY

Looking back on 2024, we gained invaluable learnings from leaders and collision spaces around the world. A notable space for us was the growing field of targeted protein degradation (TPD). What makes TPD and induced proximity different? What does it mean to “degrade” proteins, and why does it matter for patient health? We share our insights from two key conferences in our latest article 👇 https://bit.ly/4f2woLO

What the HEK? Cool new data! 👀 How does the glycosylation and activity of our fly-derived prolactin compare with prolactin from E. coli and HEK293 cells? Our latest tech note compiles the results and conclusions 👉 https://bit.ly/4idSo9t

What's the scoop on Instar 1.0? 🪰 Our co-founder and COO, Jalene Anderson-Baron, answers 3 FAQs about our new biofactory. 👇 Missed the news? Read the full story 👉 https://lnkd.in/g-4rQcad

📣 New characterization data of our fly-derived prolactin shows insights into glycosylation and activity, and how it compares with prolactin recombinantly expressed in E. coli and HEK293 systems. Read the tech note 👇 https://bit.ly/3CIEw6J